Hmdb loader
Record Information
Version5.0
StatusExpected but not Quantified
Creation Date2012-09-06 15:16:52 UTC
Update Date2022-03-07 02:52:03 UTC
HMDB IDHMDB0015631
Secondary Accession Numbers
  • HMDB15631
Metabolite Identification
Common NameAlvimopan
DescriptionAlvimopan, also known as entereg, belongs to the class of organic compounds known as hybrid peptides. Hybrid peptides are compounds containing at least two different types of amino acids (alpha, beta, gamma, delta) linked to each other through a peptide bond. Alvimopan is a drug which is used to accelerate the time to upper and lower gastrointestinal recovery following partial large or small bowel resection surgery with primary anastomosis. also investigated for use in the treatment of pain (acute or chronic). Alvimopan is a very strong basic compound (based on its pKa). In humans, alvimopan is involved in alvimopan action pathway. Alvimopan is indicated in people to avoid postoperative ileus following partial large or small bowel resection with primary anastomosis. Unlike methylnaltrexone (another peripherally acting μ-receptor antagonist) that bears a quaternary amine, alvimopan owes its selectivity for peripheral receptors to its kinetics. Gut metabolism produces an active metabolite with no clinically significant contribution to drug effect. Therefore, no interactions are expected with hepatically metabolized drugs. Alvimopan is substrate for P-glycoprotein.
Structure
Data?1582753318
Synonyms
ValueSource
ADL 8-2698EnteregHMDB
ADL 8-2698HMDB
Anhydrous alvimopanHMDB
trans-3,4-Dimethyl-4-(3-hydroxyphenyl) piperidineHMDB
EnteregHMDB
Alvimopan anhydrousHMDB
Chemical FormulaC25H32N2O4
Average Molecular Weight424.5326
Monoisotopic Molecular Weight424.236207522
IUPAC Name2-[(2S)-2-benzyl-3-[(3R,4R)-4-(3-hydroxyphenyl)-3,4-dimethylpiperidin-1-yl]propanamido]acetic acid
Traditional Namealvimopan
CAS Registry Number156053-89-3
SMILES
C[C@H]1CN(C[C@H](CC2=CC=CC=C2)C(=O)NCC(O)=O)CC[C@@]1(C)C1=CC(O)=CC=C1
InChI Identifier
InChI=1S/C25H32N2O4/c1-18-16-27(12-11-25(18,2)21-9-6-10-22(28)14-21)17-20(24(31)26-15-23(29)30)13-19-7-4-3-5-8-19/h3-10,14,18,20,28H,11-13,15-17H2,1-2H3,(H,26,31)(H,29,30)/t18-,20-,25+/m0/s1
InChI KeyUPNUIXSCZBYVBB-JVFUWBCBSA-N
Chemical Taxonomy
Description Belongs to the class of organic compounds known as hybrid peptides. Hybrid peptides are compounds containing at least two different types of amino acids (alpha, beta, gamma, delta) linked to each other through a peptide bond.
KingdomOrganic compounds
Super ClassOrganic acids and derivatives
ClassPeptidomimetics
Sub ClassHybrid peptides
Direct ParentHybrid peptides
Alternative Parents
Substituents
  • Hybrid peptide
  • N-acyl-alpha amino acid or derivatives
  • N-acyl-alpha-amino acid
  • Phenylpiperidine
  • Beta amino acid or derivatives
  • Alpha-amino acid or derivatives
  • 1-hydroxy-4-unsubstituted benzenoid
  • 1-hydroxy-2-unsubstituted benzenoid
  • Phenol
  • Aralkylamine
  • Monocyclic benzene moiety
  • Benzenoid
  • Piperidine
  • Fatty acyl
  • Fatty amide
  • Amino acid or derivatives
  • Tertiary aliphatic amine
  • Tertiary amine
  • Secondary carboxylic acid amide
  • Carboxamide group
  • Amino acid
  • Carboxylic acid derivative
  • Carboxylic acid
  • Azacycle
  • Organoheterocyclic compound
  • Monocarboxylic acid or derivatives
  • Amine
  • Organic nitrogen compound
  • Hydrocarbon derivative
  • Carbonyl group
  • Organic oxide
  • Organic oxygen compound
  • Organopnictogen compound
  • Organooxygen compound
  • Organonitrogen compound
  • Aromatic heteromonocyclic compound
Molecular FrameworkAromatic heteromonocyclic compounds
External DescriptorsNot Available
Ontology
Physiological effectNot Available
Disposition
Process
RoleNot Available
Physical Properties
StateSolid
Experimental Molecular Properties
PropertyValueReference
Melting PointNot AvailableNot Available
Boiling PointNot AvailableNot Available
Water Solubility0.0083 g/LNot Available
LogPNot AvailableNot Available
Experimental Chromatographic PropertiesNot Available
Predicted Molecular Properties
PropertyValueSource
Water Solubility0.0083 g/LALOGPS
logP3.25ALOGPS
logP0.82ChemAxon
logS-4.7ALOGPS
pKa (Strongest Acidic)3.71ChemAxon
pKa (Strongest Basic)10.66ChemAxon
Physiological Charge0ChemAxon
Hydrogen Acceptor Count5ChemAxon
Hydrogen Donor Count3ChemAxon
Polar Surface Area89.87 ŲChemAxon
Rotatable Bond Count8ChemAxon
Refractivity120.56 m³·mol⁻¹ChemAxon
Polarizability46.77 ųChemAxon
Number of Rings3ChemAxon
BioavailabilityYesChemAxon
Rule of FiveYesChemAxon
Ghose FilterYesChemAxon
Veber's RuleNoChemAxon
MDDR-like RuleYesChemAxon
Predicted Chromatographic Properties

Predicted Collision Cross Sections

PredictorAdduct TypeCCS Value (Å2)Reference
DarkChem[M+H]+200.27331661259
DarkChem[M-H]-196.53631661259
DeepCCS[M+H]+193.16830932474
DeepCCS[M-H]-190.77230932474
DeepCCS[M-2H]-223.65630932474
DeepCCS[M+Na]+199.35730932474
AllCCS[M+H]+203.932859911
AllCCS[M+H-H2O]+201.632859911
AllCCS[M+NH4]+206.032859911
AllCCS[M+Na]+206.732859911
AllCCS[M-H]-202.032859911
AllCCS[M+Na-2H]-202.732859911
AllCCS[M+HCOO]-203.632859911

Predicted Kovats Retention Indices

Underivatized

MetaboliteSMILESKovats RI ValueColumn TypeReference
AlvimopanC[C@H]1CN(C[C@H](CC2=CC=CC=C2)C(=O)NCC(O)=O)CC[C@@]1(C)C1=CC(O)=CC=C14276.0Standard polar33892256
AlvimopanC[C@H]1CN(C[C@H](CC2=CC=CC=C2)C(=O)NCC(O)=O)CC[C@@]1(C)C1=CC(O)=CC=C12347.0Standard non polar33892256
AlvimopanC[C@H]1CN(C[C@H](CC2=CC=CC=C2)C(=O)NCC(O)=O)CC[C@@]1(C)C1=CC(O)=CC=C13604.5Semi standard non polar33892256

Derivatized

Derivative Name / StructureSMILESKovats RI ValueColumn TypeReference
Alvimopan,1TMS,isomer #1C[C@H]1CN(C[C@H](CC2=CC=CC=C2)C(=O)NCC(=O)O[Si](C)(C)C)CC[C@@]1(C)C1=CC=CC(O)=C13447.0Semi standard non polar33892256
Alvimopan,1TMS,isomer #2C[C@H]1CN(C[C@H](CC2=CC=CC=C2)C(=O)NCC(=O)O)CC[C@@]1(C)C1=CC=CC(O[Si](C)(C)C)=C13494.3Semi standard non polar33892256
Alvimopan,1TMS,isomer #3C[C@H]1CN(C[C@H](CC2=CC=CC=C2)C(=O)N(CC(=O)O)[Si](C)(C)C)CC[C@@]1(C)C1=CC=CC(O)=C13421.5Semi standard non polar33892256
Alvimopan,2TMS,isomer #1C[C@H]1CN(C[C@H](CC2=CC=CC=C2)C(=O)NCC(=O)O[Si](C)(C)C)CC[C@@]1(C)C1=CC=CC(O[Si](C)(C)C)=C13422.5Semi standard non polar33892256
Alvimopan,2TMS,isomer #2C[C@H]1CN(C[C@H](CC2=CC=CC=C2)C(=O)N(CC(=O)O[Si](C)(C)C)[Si](C)(C)C)CC[C@@]1(C)C1=CC=CC(O)=C13366.7Semi standard non polar33892256
Alvimopan,2TMS,isomer #3C[C@H]1CN(C[C@H](CC2=CC=CC=C2)C(=O)N(CC(=O)O)[Si](C)(C)C)CC[C@@]1(C)C1=CC=CC(O[Si](C)(C)C)=C13411.5Semi standard non polar33892256
Alvimopan,3TMS,isomer #1C[C@H]1CN(C[C@H](CC2=CC=CC=C2)C(=O)N(CC(=O)O[Si](C)(C)C)[Si](C)(C)C)CC[C@@]1(C)C1=CC=CC(O[Si](C)(C)C)=C13389.0Semi standard non polar33892256
Alvimopan,3TMS,isomer #1C[C@H]1CN(C[C@H](CC2=CC=CC=C2)C(=O)N(CC(=O)O[Si](C)(C)C)[Si](C)(C)C)CC[C@@]1(C)C1=CC=CC(O[Si](C)(C)C)=C13350.7Standard non polar33892256
Alvimopan,3TMS,isomer #1C[C@H]1CN(C[C@H](CC2=CC=CC=C2)C(=O)N(CC(=O)O[Si](C)(C)C)[Si](C)(C)C)CC[C@@]1(C)C1=CC=CC(O[Si](C)(C)C)=C13829.7Standard polar33892256
Alvimopan,1TBDMS,isomer #1C[C@H]1CN(C[C@H](CC2=CC=CC=C2)C(=O)NCC(=O)O[Si](C)(C)C(C)(C)C)CC[C@@]1(C)C1=CC=CC(O)=C13698.6Semi standard non polar33892256
Alvimopan,1TBDMS,isomer #2C[C@H]1CN(C[C@H](CC2=CC=CC=C2)C(=O)NCC(=O)O)CC[C@@]1(C)C1=CC=CC(O[Si](C)(C)C(C)(C)C)=C13732.9Semi standard non polar33892256
Alvimopan,1TBDMS,isomer #3C[C@H]1CN(C[C@H](CC2=CC=CC=C2)C(=O)N(CC(=O)O)[Si](C)(C)C(C)(C)C)CC[C@@]1(C)C1=CC=CC(O)=C13706.2Semi standard non polar33892256
Alvimopan,2TBDMS,isomer #1C[C@H]1CN(C[C@H](CC2=CC=CC=C2)C(=O)NCC(=O)O[Si](C)(C)C(C)(C)C)CC[C@@]1(C)C1=CC=CC(O[Si](C)(C)C(C)(C)C)=C13852.6Semi standard non polar33892256
Alvimopan,2TBDMS,isomer #2C[C@H]1CN(C[C@H](CC2=CC=CC=C2)C(=O)N(CC(=O)O[Si](C)(C)C(C)(C)C)[Si](C)(C)C(C)(C)C)CC[C@@]1(C)C1=CC=CC(O)=C13853.8Semi standard non polar33892256
Alvimopan,2TBDMS,isomer #3C[C@H]1CN(C[C@H](CC2=CC=CC=C2)C(=O)N(CC(=O)O)[Si](C)(C)C(C)(C)C)CC[C@@]1(C)C1=CC=CC(O[Si](C)(C)C(C)(C)C)=C13908.4Semi standard non polar33892256
Alvimopan,3TBDMS,isomer #1C[C@H]1CN(C[C@H](CC2=CC=CC=C2)C(=O)N(CC(=O)O[Si](C)(C)C(C)(C)C)[Si](C)(C)C(C)(C)C)CC[C@@]1(C)C1=CC=CC(O[Si](C)(C)C(C)(C)C)=C14055.7Semi standard non polar33892256
Alvimopan,3TBDMS,isomer #1C[C@H]1CN(C[C@H](CC2=CC=CC=C2)C(=O)N(CC(=O)O[Si](C)(C)C(C)(C)C)[Si](C)(C)C(C)(C)C)CC[C@@]1(C)C1=CC=CC(O[Si](C)(C)C(C)(C)C)=C13945.1Standard non polar33892256
Alvimopan,3TBDMS,isomer #1C[C@H]1CN(C[C@H](CC2=CC=CC=C2)C(=O)N(CC(=O)O[Si](C)(C)C(C)(C)C)[Si](C)(C)C(C)(C)C)CC[C@@]1(C)C1=CC=CC(O[Si](C)(C)C(C)(C)C)=C14020.4Standard polar33892256
Spectra

GC-MS Spectra

Spectrum TypeDescriptionSplash KeyDeposition DateSourceView
Predicted GC-MSPredicted GC-MS Spectrum - Alvimopan GC-MS (Non-derivatized) - 70eV, Positivesplash10-0fr6-5947300000-a56d3fba4a79398cd53e2017-09-01Wishart LabView Spectrum
Predicted GC-MSPredicted GC-MS Spectrum - Alvimopan GC-MS (2 TMS) - 70eV, Positivesplash10-0fkc-9030260000-07291dc02727a1b76e9c2017-10-06Wishart LabView Spectrum
Predicted GC-MSPredicted GC-MS Spectrum - Alvimopan GC-MS (Non-derivatized) - 70eV, PositiveNot Available2021-10-12Wishart LabView Spectrum
Predicted GC-MSPredicted GC-MS Spectrum - Alvimopan GC-MS (Non-derivatized) - 70eV, PositiveNot Available2021-10-12Wishart LabView Spectrum

MS/MS Spectra

Spectrum TypeDescriptionSplash KeyDeposition DateSourceView
Predicted LC-MS/MSPredicted LC-MS/MS Spectrum - Alvimopan 10V, Positive-QTOFsplash10-00b9-4135900000-cdd9dcd5c0e44a4d2c3a2016-06-03Wishart LabView Spectrum
Predicted LC-MS/MSPredicted LC-MS/MS Spectrum - Alvimopan 20V, Positive-QTOFsplash10-00di-7659100000-c6c4baaf84ffc4a524ff2016-06-03Wishart LabView Spectrum
Predicted LC-MS/MSPredicted LC-MS/MS Spectrum - Alvimopan 40V, Positive-QTOFsplash10-01ba-4921000000-1d5e9cec550e68fc676d2016-06-03Wishart LabView Spectrum
Predicted LC-MS/MSPredicted LC-MS/MS Spectrum - Alvimopan 10V, Negative-QTOFsplash10-00di-0013900000-26c80cc1229d409f18b02016-08-03Wishart LabView Spectrum
Predicted LC-MS/MSPredicted LC-MS/MS Spectrum - Alvimopan 20V, Negative-QTOFsplash10-0fk9-2389700000-5887ae4c83be056c9be42016-08-03Wishart LabView Spectrum
Predicted LC-MS/MSPredicted LC-MS/MS Spectrum - Alvimopan 40V, Negative-QTOFsplash10-0udi-7690000000-04222ab40d4c3cdf96dd2016-08-03Wishart LabView Spectrum
Predicted LC-MS/MSPredicted LC-MS/MS Spectrum - Alvimopan 10V, Positive-QTOFsplash10-004i-0116900000-7e677f87932e437c28b82021-10-11Wishart LabView Spectrum
Predicted LC-MS/MSPredicted LC-MS/MS Spectrum - Alvimopan 20V, Positive-QTOFsplash10-056r-0179500000-9a36c62b4f259dfc6d002021-10-11Wishart LabView Spectrum
Predicted LC-MS/MSPredicted LC-MS/MS Spectrum - Alvimopan 40V, Positive-QTOFsplash10-014i-1921000000-c9da581bb4acc528324a2021-10-11Wishart LabView Spectrum
Predicted LC-MS/MSPredicted LC-MS/MS Spectrum - Alvimopan 10V, Negative-QTOFsplash10-00fr-0009800000-6c5de1cc3dd55967c60b2021-10-11Wishart LabView Spectrum
Predicted LC-MS/MSPredicted LC-MS/MS Spectrum - Alvimopan 20V, Negative-QTOFsplash10-00fr-4509100000-844a82b338df3daf6e8e2021-10-11Wishart LabView Spectrum
Predicted LC-MS/MSPredicted LC-MS/MS Spectrum - Alvimopan 40V, Negative-QTOFsplash10-01b9-7975000000-248c5b20b32a461b463d2021-10-11Wishart LabView Spectrum
Biological Properties
Cellular Locations
  • Membrane
Biospecimen Locations
  • Blood
  • Urine
Tissue LocationsNot Available
Pathways
Normal Concentrations
BiospecimenStatusValueAgeSexConditionReferenceDetails
BloodExpected but not QuantifiedNot QuantifiedNot AvailableNot AvailableTaking drug identified by DrugBank entry DB06274 details
UrineExpected but not QuantifiedNot QuantifiedNot AvailableNot AvailableTaking drug identified by DrugBank entry DB06274 details
Abnormal Concentrations
Not Available
Associated Disorders and Diseases
Disease ReferencesNone
Associated OMIM IDsNone
DrugBank IDDB06274
Phenol Explorer Compound IDNot Available
FooDB IDNot Available
KNApSAcK IDNot Available
Chemspider ID4589864
KEGG Compound IDNot Available
BioCyc IDNot Available
BiGG IDNot Available
Wikipedia LinkAlvimopan
METLIN IDNot Available
PubChem Compound5488548
PDB IDNot Available
ChEBI ID535293
Food Biomarker OntologyNot Available
VMH IDNot Available
MarkerDB IDNot Available
Good Scents IDNot Available
References
Synthesis ReferenceNot Available
Material Safety Data Sheet (MSDS)Not Available
General References
  1. [No authors listed] [PubMed:18373729 ]
  2. Wang S, Shah N, Philip J, Caraccio T, Feuerman M, Malone B: Role of alvimopan (entereg) in gastrointestinal recovery and hospital length of stay after bowel resection. P T. 2012 Sep;37(9):518-25. [PubMed:23066346 ]
  3. FDA [Link]

Enzymes

General function:
Involved in G-protein coupled receptor protein signaling pathway
Specific function:
Inhibits neurotransmitter release by reducing calcium ion currents and increasing potassium ion conductance. Highly stereoselective. receptor for enkephalins
Gene Name:
OPRD1
Uniprot ID:
P41143
Molecular weight:
40412.3
References
  1. Neary P, Delaney CP: Alvimopan. Expert Opin Investig Drugs. 2005 Apr;14(4):479-88. [PubMed:15882122 ]
  2. Beattie DT, Cheruvu M, Mai N, O'Keefe M, Johnson-Rabidoux S, Peterson C, Kaufman E, Vickery R: The in vitro pharmacology of the peripherally restricted opioid receptor antagonists, alvimopan, ADL 08-0011 and methylnaltrexone. Naunyn Schmiedebergs Arch Pharmacol. 2007 May;375(3):205-20. Epub 2007 Mar 6. [PubMed:17340127 ]
General function:
Involved in G-protein coupled receptor protein signaling pathway
Specific function:
Inhibits neurotransmitter release by reducing calcium ion currents and increasing potassium ion conductance. Receptor for beta-endorphin
Gene Name:
OPRM1
Uniprot ID:
P35372
Molecular weight:
44778.9
References
  1. Kraft MD: Emerging pharmacologic options for treating postoperative ileus. Am J Health Syst Pharm. 2007 Oct 15;64(20 Suppl 13):S13-20. [PubMed:17909271 ]
  2. [No authors listed] [PubMed:18373729 ]
  3. Saufl NM, Strzyzewski N: Nurses are everywhere: a practical perspective on the surgical team in managing postoperative ileus. J Perianesth Nurs. 2006 Apr;21(2A Suppl):S24-9. [PubMed:16597533 ]
  4. Chen X, Ji ZL, Chen YZ: TTD: Therapeutic Target Database. Nucleic Acids Res. 2002 Jan 1;30(1):412-5. [PubMed:11752352 ]
  5. Neary P, Delaney CP: Alvimopan. Expert Opin Investig Drugs. 2005 Apr;14(4):479-88. [PubMed:15882122 ]
  6. Schmidt WK: Alvimopan* (ADL 8-2698) is a novel peripheral opioid antagonist. Am J Surg. 2001 Nov;182(5A Suppl):27S-38S. [PubMed:11755894 ]
General function:
Involved in G-protein coupled receptor protein signaling pathway
Specific function:
Inhibits neurotransmitter release by reducing calcium ion currents and increasing potassium ion conductance. Receptor for dynorphins. May play a role in arousal and regulation of autonomic and neuroendocrine functions
Gene Name:
OPRK1
Uniprot ID:
P41145
Molecular weight:
42644.7
References
  1. Beattie DT, Cheruvu M, Mai N, O'Keefe M, Johnson-Rabidoux S, Peterson C, Kaufman E, Vickery R: The in vitro pharmacology of the peripherally restricted opioid receptor antagonists, alvimopan, ADL 08-0011 and methylnaltrexone. Naunyn Schmiedebergs Arch Pharmacol. 2007 May;375(3):205-20. Epub 2007 Mar 6. [PubMed:17340127 ]
  2. Neary P, Delaney CP: Alvimopan. Expert Opin Investig Drugs. 2005 Apr;14(4):479-88. [PubMed:15882122 ]